Clinical data aligned with these findings, showing that lower VCAM1 expression correlates with prolonged survival in low-grade glioma patients, but not in glioblastoma.<h4>Conclusion</h4>Astrocyte-derived VCAM1 is a critical driver of glioma progression, mediating essential interactions between tumor cells and the TME. This evidence concerns the gene VCAM1 and central nervous system cancer.